V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 250011027 | 250008220 | null | null | Disease modification (D) | 2017-11-16 | 2017-11-23 | Rituximab | N | N | 250015208 | NOT MATCHED |
| 250011028 | 250008221 | null | 89.5 | Palliative (P) | 2017-06-14 | 2017-06-16 | R GCVP | N | N | 250015873 | CARBOPLATIN + ETOPOSIDE |
| 250011029 | 250008221 | 1.71 | 77 | null | 2017-07-08 | 2017-07-08 | Abiraterone | 2 | N | 250015873 | PEMETREXED |
| 250011030 | 250008223 | 1.73 | 74 | Palliative (P) | 2015-05-01 | 2015-05-15 | GEMCARBO | 02 | N | 250016315 | PEMETREXED |
| 250011031 | 250008225 | null | 64.5 | Curative (C) | 2018-05-22 | 2018-05-30 | IPM | N | null | 250016427 | IRINOTECAN + MDG |
| 250011032 | 250008225 | null | null | Palliative (P) | 2017-06-26 | 2017-06-26 | ALEMTUZUMAB + BUSULFAN + FLUDARABINE | 02 | N | 250016427 | RITUXIMAB |
| 250011033 | 250008226 | 1.74 | 71.3 | Disease modification (D) | 2015-11-07 | 2015-11-07 | IPM | N | N | 250016619 | IPM |
| 250011034 | 250008226 | 1.56 | 74.4 | Palliative (P) | 2015-11-28 | 2016-01-10 | Cytarabine Low Dose | 01 | N | 250016619 | GEMCARBO |
| 250011035 | 250008227 | null | null | Palliative (P) | 2015-12-07 | 2015-12-07 | Azacitidine | 99 | N | 250017056 | NOT MATCHED |
| 250011036 | 250008229 | 1.62 | 82.3 | Disease modification (D) | 2015-09-23 | 2015-09-24 | null | 2 | Y | 250017200 | GEMCARBO |
| 250011037 | 250008231 | 1.61 | null | Palliative (P) | 2015-07-07 | 2015-07-07 | Carboplatin AUC 6 - 10 | 02 | null | 250017201 | EOX |
| 250011038 | 250008232 | 1.82 | 89.1 | Palliative (P) | 2017-12-09 | 2017-12-14 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN | N | N | 250017208 | CAPECITABINE |
| 250011039 | 250008233 | 1.71 | 62.4 | Palliative (P) | 2017-04-22 | 2017-09-18 | GemCarbo Days 1+8 | N | N | 250017259 | IPM |
| 250011040 | 250008234 | 1.64 | 74 | Palliative (P) | 2016-07-03 | 2016-07-03 | Busulfan Oral | 2 | N | 250017324 | DA |
| 250011041 | 250008235 | 1.73 | 104 | Disease modification (D) | 2017-10-14 | 2017-10-23 | PEMBROLIZUMAB | N | N | 250017324 | CYTARABINE |
| 250011042 | 250008236 | 1.76 | 81.9 | Adjuvant (A) | 2016-02-26 | 2016-05-25 | null | N | N | 250017799 | CISPLATIN + GEMCITABINE |
| 250011043 | 250011078 | 1.62 | 51.8 | Disease modification (D) | 2017-03-28 | 2017-04-02 | GemCarbo Days 1+8 | null | N | 250017799 | CISPLATIN + GEMCITABINE |
| 250011044 | 250011079 | 1.63 | 94.4 | Palliative (P) | 2018-09-25 | 2018-09-25 | GemCarbo Days 1+8 | 2 | N | 250018091 | CARBOPLATIN + PACLITAXEL |
| 250011045 | 250008239 | 1.73 | 98.7 | Disease modification (D) | 2017-03-24 | 2017-04-07 | IPM | N | N | 250018099 | CARBOPLATIN + VINORELBINE |
| 250011046 | 250008240 | 0 | 0 | Curative (C) | 2017-05-09 | 2017-05-13 | CARBOPLATIN + VINORELBINE | N | N | 250018262 | NOT MATCHED |
| 250011047 | 250008243 | null | null | null | 2016-12-17 | 2017-04-03 | GemCarbo Days 1+8 | N | N | 250018361 | GEMCITABINE |
| 250011048 | 250011081 | 1.68 | 70 | Palliative (P) | 2015-03-22 | 2015-03-24 | GemCarbo Days 1+8 | 2 | N | 250018524 | NOT MATCHED |
| 250011049 | 250008245 | 1.69 | 0 | Palliative (P) | 2016-02-07 | 2016-06-27 | ANAGRELIDE | Y | N | 250018706 | GEMCARBO |
| 250011050 | 250008246 | 1.62 | 63.7 | Disease modification (D) | 2016-06-02 | 2016-06-08 | Carboplatin + Etoposide IV 3 day | 02 | N | 250018713 | IPM |
| 250011051 | 250008246 | 1.72 | null | Disease modification (D) | 2018-08-18 | 2018-08-26 | COMMAND trial | 02 | N | 250018713 | GEMCARBO |
| 250011052 | 250008248 | null | 60 | Palliative (P) | 2019-05-14 | 2019-05-19 | GemCarbo Days 1+8 | 2 | N | 250019028 | PEMETREXED |
| 250011053 | 250012197 | null | 48.7 | Palliative (P) | 2015-05-15 | 2015-05-15 | Azacitidine | Y | N | 250019032 | BEVACIZUMAB |
| 250011054 | 250008250 | 1.73 | 71 | Curative (C) | 2018-05-13 | 2018-05-13 | IPM | Y | Y | 250019175 | NOT MATCHED |
| 250011055 | 250008250 | 1.78 | 65.5 | Palliative (P) | 2017-02-10 | 2017-02-10 | IBRUTINIB | 02 | N | 250019175 | COMMAND TRIAL |
| 250011056 | 250008252 | 1.8 | 97 | Disease modification (D) | 2017-12-05 | 2017-12-05 | IPM | 2 | N | 250019336 | IPM |
| 250011057 | 250008252 | 1.79 | 96 | Palliative (P) | 2017-12-18 | 2017-12-19 | BUSULFAN + FLUDARABINE | Y | null | 250019336 | DA |
| 250011058 | 250008253 | null | 79.5 | null | 2018-07-21 | 2018-08-04 | Bortezomib +/- Dexamethasone | 02 | N | 250019583 | IPM |
| 250011059 | 250012201 | 0 | 90 | Adjuvant (A) | 2016-06-03 | 2016-09-24 | COMMAND trial | N | N | 250019592 | GEMCITABINE |
| 250011060 | 250008254 | 1.65 | 49 | Palliative (P) | 2016-12-14 | 2016-12-14 | Azacitidine | 2 | N | 250019777 | CHLORAMBUCIL + OFATUMUMAB |
| 250011061 | 250008255 | 0 | 49 | Palliative (P) | 2018-07-09 | 2018-12-05 | Rituximab | 1 | N | 250019777 | IPM |
| 250011062 | 250008258 | 0 | 76.2 | Palliative (P) | 2014-09-16 | 2014-10-05 | BUSULFAN | N | N | 250020140 | EVEROLIMUS |
| 250011063 | 250008259 | 1.87 | 63 | Palliative (P) | 2014-08-17 | 2014-08-17 | GemCarbo Days 1+8 | 02 | N | 250020140 | CARBOPLATIN + ETOPOSIDE |
| 250011064 | 250008264 | 1.7 | 86.8 | Palliative (P) | 2017-10-01 | 2017-10-31 | IPM | 2 | N | 250020418 | PEMETREXED |
| 250011065 | 250008265 | null | 77.1 | Disease modification (D) | 2018-10-10 | 2018-10-16 | Abiraterone | N | N | 250020985 | GEMCARBO |
| 250011066 | 250008266 | 0 | 48 | Adjuvant (A) | null | 2018-02-15 | Melphalan IV High dose | N | N | 250021165 | SPIRE TRIAL |
| 250011067 | 250008267 | 1.67 | null | null | 2017-06-25 | 2017-07-16 | Azacitidine | N | N | 250021813 | IPM |
| 250011068 | 250008268 | 0 | 95.1 | Palliative (P) | 2014-08-15 | 2014-08-22 | Venetoclax | N | N | 250021867 | CISPLATIN + IRINOTECAN |
| 250011069 | 250008269 | 1.56 | 119 | Palliative (P) | 2017-05-27 | 2017-07-01 | IPM | null | N | 250021887 | LENALIDOMIDE |
| 250011070 | 250008270 | 1.69 | 0 | Curative (C) | 2018-04-10 | 2018-04-10 | Oxaliplatin + Modified de Gramont | N | N | 250022352 | GEMCARBO |
| 250011071 | 250008271 | 1.83 | 64.9 | Palliative (P) | null | 2019-05-11 | Nilotinib | N | N | 250022714 | FEC + DOCETAXEL |
| 250011072 | 250011096 | 1.7 | 84.8 | Palliative (P) | 2014-04-24 | 2015-11-10 | GemCarbo Days 1+8 | N | N | 250023187 | CARBOPLATIN + PACLITAXEL |
| 250011073 | 250008272 | 0 | 86 | Palliative (P) | 2018-07-25 | 2018-07-25 | INTERFERON | N | N | 250023193 | NOT MATCHED |
| 250011074 | 250008272 | 1.8 | 83.7 | Disease modification (D) | 2015-01-08 | 2015-01-08 | IPM | 02 | N | 250023193 | CARBOPLATIN |
| 250011075 | 250008273 | 1.65 | 70.4 | Palliative (P) | null | 2018-10-21 | GEMCARBO | N | N | 250024343 | NOT MATCHED |
| 250011076 | 250008273 | 1.78 | 102 | Palliative (P) | 2017-10-28 | 2017-10-28 | COMMAND trial | N | N | 250024343 | GEMCARBO |